K/DOQI practice guidelines for bone metabolism and disease in chronic kidney disease: Another opportunity for renal dietitians to take a leadership role in improving outcomes for patients with chronic kidney disease

Journal of Renal Nutrition

Volumn 15, Issue 2, 2005, Pages 265-274

  McCann, Linda ^a  

^a CA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; ERGOCALCIFEROL; PHOSPHATE BINDING AGENT; SEVELAMER;

ALUMINUM OVERLOAD; BLOOD VESSEL CALCIFICATION; BONE DISEASE; BONE METABOLISM; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CHRONIC KIDNEY DISEASE; DIETITIAN; HUMAN; KIDNEY FUNCTION; LEADERSHIP; LUNG CALCIFICATION; LUNG FUNCTION; MINERAL METABOLISM; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PRACTICE GUIDELINE; REVIEW; SOFT TISSUE CALCIFICATION; TREATMENT OUTCOME; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 17044430596     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2005.01.002     Document Type: Review

References (13)

1. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease Am J Kidney Dis 42 suppl 3 2003 S1 S202
2. M. Wang, G. Hercz, D.J. Sherrard Relationship between intact 1-84 PTH and bone histomorphometric parameters in dialysis patients without aluminum toxicity Am J Kidney Dis 26 1995 836 844
3. P. Kurz, M.C. Monier-Faugere, B. Bodnar Evidence for abnormal calcium homeostasis in patients with adynamic bone disease Kidney Int 46 1994 855 861
4. G. Hercz, Y. Pei, C. Greenwood Aplastic osteodystrophy without aluminum The role of "suppressed" parathyroid function Kidney Int 44 1993 860 866
5. H. Malluche, M.C. Faugere Renal bone disease 1990 An unmet challenge for the nephrologists Kidney Int 38 1990 193 211
6. I. Martinez, R. Saracho, J. Montenegro The importance of dietary calcium and phosphorus in the secondary HPT of patients in early renal failure Am J Kidney Dis 29 1997 496 502
7. F. Llach, S.G. Massry On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency J Clin Endocrinol Metab 61 1985 601 606
8. G. Block, K. Port Calcium phosphate metabolism and cardiovascular disease in patients with CKD Semin Dial 16 2003 140 147
9. G.A. Block, T.E. Hulbert-Shearon, N.W. Levin Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients; a national study Am J Kidney Dis 31 1998 607 617
10. M.S. Sheikh, J.A. Maguire, M. Emmett Reduction of dietary phosphorus absorption by phosphorus binders A theoretical, in vivo, and in vivo study J Clin Invest 83 1989 66 73
11. G.M. Chertow, M.A. Dillon, N. Amin Sevelamer with and without calcium and vitamin D Observations from a long-term open-label clinical trial J Ren Nutr 10 2000 25 132
12. N. Tessitore, A. Venturi, S. Adami Relationship between vitamin D metabolites and dietary intake of phosphate in patients with early renal failure Miner Electrolyte Metab 13 1987 38 44
13. S. Lopez-Hilker, A.S. Dusso, N.S. Rapp Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol Am J Physiol 259 1990 F432 F437